AI News about pharmaceutical
Latest news and AI summaries about pharmaceutical · 11 articles
About pharmaceutical
Latest AI-curated news and analysis about pharmaceutical, including breaking stories, expert analysis, and global coverage. Updated in real-time with AI-powered summaries to keep you informed.
Related: health · biopharmaceutical · life · sciences · grifols
Trending Topics
Emmaus Life Sciences Reports Annual Financial Results
Emmaus Life Sciences Posts 2025 Annual Results Emmaus Life Sciences, a biopharmaceutical company specializing in sickle cell disease treatment, released its 2025 financial results. The OTCQB-listed firm reported on its operational performance and financial condition for the year ending December 31, 2025. The announcement marks the company's latest update on its commercial-stage initiatives.
Biotech, Pharmaceutical and Clinical Research Jobs | BioSpace · 2026.04.02
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Lilly Acquires Centessa to Expand Sleep Disorder Pipeline Eli Lilly is acquiring Centessa Pharmaceuticals in a strategic move to advance its portfolio of sleep-wake disorder treatments. The clinical-stage company brings novel therapeutics that complement Lilly's existing neuroscience pipeline. This acquisition strengthens Lilly's position in the growing sleep medicine market.
PR Newswire: press release distribution, targeting, monitoring and marketing · 2026.04.01
Health News Highlights: Genetic Cloning Concerns, Insulin Price Cap, and Eye Drug Milestones | Health
Grifols' US Biopharma Unit IPO Strengthens Market Position Spanish pharmaceutical giant Grifols is launching an initial public offering of its US-based biopharma business while retaining a minority stake and maintaining its primary listing in Spain. The strategic move aims to enhance the company's competitive standing in the biopharmaceutical sector and secure additional capital for growth initiatives.
Devdiscourse · 2026.03.27
Global Health Industry Headlines: IPOs, Drug Breakthroughs, and Policy Shifts | Health
Grifols Plans US Biotech IPO, Maintains Majority Control Spanish pharmaceutical giant Grifols is taking its US biopharma division public through an initial public offering while retaining majority ownership. The company will float a minority stake, allowing it to raise capital while keeping strategic control. This move reflects growing trends of healthcare companies restructuring to optimize valuations.
Devdiscourse · 2026.03.27
Geopolitics and Drug Shortages | Science-Based Medicine
Iran War Disrupts Global Drug Supply Chains Geopolitical tensions are creating critical pharmaceutical shortages worldwide as supply chains face unprecedented strain. The conflict is exposing vulnerabilities in drug manufacturing and distribution networks that depend on stable international trade. Healthcare systems globally must now adapt to potential medicine scarcity.
Science-Based Medicine · 2026.03.27
Technology: AstraZeneca subject to cyberattacks
AstraZeneca Hit by Ransomware in Major Pharma Cyberattack Pharmaceutical giant AstraZeneca has fallen victim to a ransomware attack, joining other high-profile targets including the Dutch Finance Ministry and defense contractor Stryker. The incidents highlight escalating cybersecurity threats against critical infrastructure and major corporations. Experts are warning organizations to strengthen defenses against sophisticated cyber threats.
RNZ · 2026.03.26
Protagonist’s First Approval Spells Trouble for Pharma’s Immunology Heavyweights
Protagonist Lands FDA Win, Threatens Immunology Giants Protagonist Therapeutics received its first FDA approval, securing a $50 million immediate payment from its Johnson & Johnson partnership. The breakthrough positions the biotech company to challenge established players in the immunology sector. Industry analysts suggest the approval could reshape competitive dynamics among major pharmaceutical immunology programs.
Biotech, Pharmaceutical and Clinical Research Jobs | BioSpace · 2026.03.19
Accord Healthcare - Business Focus
Accord Healthcare Emerges as Europe's Fastest-Growing Pharma Accord Healthcare has established itself as a leading pharmaceutical company across Europe through its extensive product portfolio and strong market presence. The company continues to expand rapidly, positioning itself among the continent's fastest-growing drug manufacturers. Its comprehensive approach spans multiple therapeutic areas and geographic markets.
2026.03.17
Life sciences and biomanufacturing
BC Launches Life Sciences Hub to Boost Biomanufacturing British Columbia is launching a comprehensive Life Sciences and Biomanufacturing Strategy to establish itself as a global hub for pharmaceutical and medical device manufacturing. The initiative aims to attract commercial-scale biopharmaceutical production and position the province as a leading centre for life sciences innovation. The strategy targets growth in high-value manufacturing sectors.
2026.03.13
Groundbreaking Developments in Health and Pharmaceutical Sector | Health
FDA Streamlines Biosimilar Testing, Slashing Drug Costs The FDA has introduced new guidelines to streamline biosimilar drug testing, dramatically reducing costs for vital biologic medications used in cancer treatment and other diseases. Despite biosimilars representing only 5% of prescriptions, they account for 51% of total drug expenditure. These regulatory changes aim to make life-saving treatments more accessible and affordable.
Devdiscourse · 2026.03.11
EVE Health Advances Reformulated Drugs Targeting Sexual Health and Cardiovascular Markets
# Summary EVE Health Group has completed R&D on reformulated drug candidates targeting sexual health and cardiovascular therapies for global pharmaceutical markets. The programs leverage the company's proprietary drug delivery and solubilisation technologies to improve therapeutic outcomes. This advancement positions EVE Health to expand its presence in these high-demand therapeutic sectors.
TradingView · 2026.03.11